Renovaro Biosciences Inc. (RENB)
NASDAQ: RENB · IEX Real-Time Price · USD
1.570
+0.130 (9.03%)
At close: Jun 21, 2024, 4:00 PM
1.490
-0.080 (-5.10%)
After-hours: Jun 21, 2024, 6:01 PM EDT

Renovaro Biosciences Market Cap

Renovaro Biosciences has a market cap or net worth of $231.58 million as of June 21, 2024. Its market cap has increased by 469.00% in one year.

Market Cap
231.58M
Enterprise Value
239.84M
1-Year Change
469.00%
Ranking
Category
Stock Price
$1.57

Market Cap Chart

Since December 11, 2018, Renovaro Biosciences's market cap has decreased from $252.00M to $231.58M, a decrease of -8.10%. That is a compound annual growth rate of -1.52%.

History

DateMarket Cap% Change
Jun 21, 2024231.60M9.04%
Jun 20, 2024212.40M-0.70%
Jun 18, 2024213.90M-8.78%
Jun 17, 2024234.50M-3.06%
Jun 14, 2024241.90M13.09%
Jun 13, 2024213.90M1.42%
Jun 12, 2024210.90M-2.09%
Jun 11, 2024215.40M-2.00%
Jun 10, 2024219.80M15.50%
Jun 7, 2024190.30M-3.01%
Jun 6, 2024196.20M-6.35%
Jun 5, 2024209.50M-2.06%
Jun 4, 2024213.90M2.84%
Jun 3, 2024208.00M-5.37%
May 31, 2024219.80M1.38%
May 30, 2024216.80M-
May 29, 2024216.80M-
May 28, 2024216.80M3.48%
May 24, 2024209.50M7.60%
May 23, 2024194.70M40.37%
May 22, 2024138.70M-2.05%
May 21, 2024141.60M-1.05%
May 20, 2024143.10M-
May 17, 2024143.10M5.76%
May 16, 2024135.30M-3.15%
View and export this data all the way back to 2018. Sign Up Today.

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding
Full Definition

Related Stocks

Company Market Cap
Prelude Therapeutics 202.14M
Akebia Therapeutics 202.13M
Q32 Bio 200.39M
Pyxis Oncology 198.45M
Aldeyra Therapeutics 198.44M
P3 Health Partners 198.39M
Nanobiotix 198.18M
Butterfly Network 198.04M
Market Cap Rankings